首页 Kitov Pharmaceuticals(usKTOV)-基本信息

Kitov Pharmaceuticals(usKTOV)-基本信息

日报更新时间:

周报更新时间:01-16 11:49

行情信息

今开价:

最高价:

成交量:

昨收价:

最低价:

最新价:

行情图标
概要信息

英文名称:Kitov Pharmaceuticals


简介:Kitov Pharma Ltd.于1968年8月12日以色列国的法律注册成立


电话:972-3-9333121


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 持股信息
  • 领导人信息

Kitov是一家专注于现有药物后期开发(仿制药)的生物制药公司,目前着重两个方面:关节炎 & 高血压。目前Kitov的产品线主要有两个,KIT-301和KIT-302。 KIT-301:基于仿制药萘普生(Naproxen)和伊拉地平(Isradipine)开发; KIT-302:基于塞来昔布(Celecoxib)和仿制药苯磺酸氨氯地平(Amlodipine besylate)开发,目前已完成III期临床试验(2015.12.15)。萘普生和塞来昔布都是目前已经获批的用于缓解关节炎疼痛的药物的活性成分,其中Celecoxib更是品牌药Celebrex®的活性成分。上面的药物组合被设计来治疗关节炎以及高血压(高血压是使用非类固醇抗炎药(Non-Steroidal Anti-Inflammatory Drugs, NSAIDs)治疗关节炎的副作用之一)。2015年12月15日,Kitov Pharmaceuticals(KTOV)宣布其产品KIT-302的第三期临床试用达到了初步效应目标,该目标为临床基准,并已获得FDA的批准。

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Sabby Management LLC -- -- -19980 -100.00% 2019-03-31
Envestnet Asset Management Inc 49689 0.26% -- -- 2019-07-31
Virtu Financial LLC 38898 0.20% 16069 70.39% 2019-03-31
Morgan Stanley - Brokerage Accounts 32400 0.17% 29700 1100.00% 2019-03-31
Alumot Mutual Funds Management Ltd 22500 0.12% -- -- 2019-07-31
Susquehanna International Group, LLP 11270 0.06% -84919 -88.28% 2019-03-31
Susquehanna Financial Group, LLLP 11270 0.06% -84919 -88.28% 2019-03-31
Menta Capital LLC 11027 0.06% -13421 -54.90% 2019-03-31
UBS Group AG 2620 0.01% -469 -15.18% 2019-03-31
Bruderman Asset Management, LLC 1770 0.01% -- -- 2019-03-31
Advisory Services Network, LLC 1450 0.01% 1450 -- 2019-03-31
TWO SIGMA SECURITIES, LLC -- -- -18580 -100.00% 2019-03-31
Citadel Advisors Llc -- -- -38720 -100.00% 2019-03-31
Wells Fargo & Co -- -- -10000 -100.00% 2019-03-31
Essex Investment Management Company, LLC -- -- -17705 -100.00% 2018-09-30
Advisor Group, Inc. -- -- -400 -100.00% 2018-06-30
UBS Securities LLC 3599 0.02% -1000 -21.74% 2018-06-30
Wells Fargo Advisors, LLC 10000 0.06% -- -- 2018-09-30
Morgan Stanley & Co Inc 48600 0.30% 48600 -- 2018-06-30
Rosalind Advisors, Inc. 385000 3.36% -720600 -65.18% 2018-05-14
Armistice Capital, LLC 760000 6.11% 760000 -- 2018-05-31
Oxford Asset Management, LLC 12321 0.11% 12321 -- 2017-12-31
Vassalluzzo Scott J 38192 0.46% 38192 -- 2017-09-30
Deutsche Bank AG 47364 0.57% -8936 -15.87% 2017-09-30
KCG AMERICAS LLC 13942 0.17% -7373 -34.59% 2017-06-30
Psagot Investment House Ltd. 34761 0.42% 34489 12679.78% 2017-06-30
Tower Research Capital LLC 397 0.01% -100 -20.12% 2016-09-30
FNY Managed Accounts LLC 5000 0.12% 5000 -- 2016-09-30
Creative Planning Inc 7875 0.19% 7875 -- 2016-09-30
JANE STREET GROUP, LLC 14201 0.34% 2887 25.52% 2016-09-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
PMC Diversified Equity Fund 49689 0.26% -- -- 2019-06-30
Alumot Flexible 12500 0.06% -- -- 2019-04-30
Alumot Overseas Equity 10000 0.05% -- -- 2019-04-30
PMC Diversified Equity 10307 0.13% 10307 -- 2016-12-31

Steven Steinberg Steven Steinberg is Chief Financial Officer of Glide Talk Ltd. Mr. Steinberg is also on the board of Kitov Pharma Ltd. He previously held the position of Vice President-Finance at Clientconnect Ltd., Chief Financial Officer-New York Operations at Health Partners, Inc., Controller at Albar Mimunit Services Ltd., Chief Financial Officer & Audit Manager at PricewaterhouseCoopers LLP, Vice President-Finance at Percite Information Technologies Ltd., Chief Financial Officer for Answers Corp., Stock Broker at Tower Asset Management LLC, Vice President at GKM Advisers LLC and Audit Manager at Coopers & Lybrand LLP. Steven Steinberg received an undergraduate degree from DePaul University, a graduate degree from John Marshall Law School (Georgia) and an undergraduate degree from Florida International University.
Gil Efron Founder of Geo Consluting Ltd., Gil Efron currently is Chief Executive Officer of Geo Consluting Ltd. and Chief Financial Officer & Deputy CEO at Kitov Pharma Ltd. Mr. Efron previously was Chief Financial Officer of IP Planet Networks Ltd., CFO, Deputy CEO & Head-Investor Relations at Kamada Ltd., Chief Financial Officer for Proficiency Ltd., Secretary at RR Media Ltd. and Senior Auditor at PricewaterhouseCoopers (Israel). Gil Efron received an undergraduate degree and an MBA from The Hebrew University of Jerusalem.
Simcha Rock Simcha Rock is on the board of Kitov Pharma Ltd. In his past career Mr. Rock was Senior Vice President of Edmond De Rothschild Private Equity Partners (Israel) Ltd. Mr. Rock received an undergraduate degree from Yeshiva University and an MBA from Cleveland State University.
Ido Agmon Ido Agmon is on the board of Kitov Pharma Ltd. and Manager at Aviv Bio-Invest. In the past Mr. Agmon held the position of Chairman for SphinxTech Ltd., Chief Executive Officer of Meytav Technological Enterprises Innovation Center Ltd. and Director-Business Development for ATI Ashkelon Technological Industries Ltd. Mr. Agmon received an MBA from The Hebrew University of Jerusalem and an undergraduate degree from Tel-Aviv University.
Gil Ben-Menachem Gil Ben-Menachem is Director & VP-Business Development at Kitov Pharma Ltd. In the past he held the position of Head-Innovative Products at Dexcel Pharma Technologies Ltd., Director-Business Development at Teva Pharmaceutical Industries Ltd. and Chief Executive Officer at OphthaliX, Inc. He received a doctorate, a graduate degree and an undergraduate degree from The Hebrew University of Jerusalem and an MBA from the University of Maryland.
John Paul Waymack Dr. John Paul Waymack is a Chief Medical Officer at Kitov Pharma Ltd. Dr. Waymack was previously employed as an Associate Professor by The University of Texas.
William Berlin Dr. William Berlin is a Manager-Chemistry, Manufacturing & Control at Kitov Pharmaceuticals Holdings Ltd.
Simcha Rock Simcha Rock is on the board of Kitov Pharma Ltd. In his past career Mr. Rock was Senior Vice President of Edmond De Rothschild Private Equity Partners (Israel) Ltd. Mr. Rock received an undergraduate degree from Yeshiva University and an MBA from Cleveland State University.
Isaac Israel Isaac Israel founded Contact Communications Ltd., Real Imaging Holdings Ltd., Uneri Capital Ltd. and Bee Contact Communications Ltd. Mr. Israel occupies the position of Chief Executive Officer & Director at Kitov Pharma Ltd. Mr. Israel is also on the board of RDD Pharma Ltd. Mr. Israel previously held the position of Chairman at Nextgen Biomed Ltd., Chief Executive Officer of Insuline Medical Ltd., Vice President-Business Development for Capital Point Ltd. Manager-Business Development at Meytag High-Tech Ventures Ltd. and Manager-Business Development at Ofakim Hi-Tech Ventures Ltd. (both are subsidiaries of Capital Point Ltd.), Chief Executive Officer for Kitov Pharma Ltd., Chief Executive Officer of Bee Contact Communications Ltd and Director at Real Imaging Holdings Ltd.
Yisrael Gewirtz Currently, Yisrael Gewirtz occupies the position of Internal Auditor of Apply Advanced Mobile Technologies Ltd., Internal Auditor for SOLEGREEN LTD., Internal Auditor for InterCure Ltd., Internal Auditor at My Size, Inc., Internal Auditor for Insuline Medical Ltd., Internal Auditor for Kadimastem Ltd., Internal Auditor at Kitov Pharma Ltd. and Internal Auditor at Energix-Renewable Energies Ltd. Mr. Gewirtz is also Partner at Fahn Kanne & Co. Yisrael Gewirtz previously held the position of Internal Auditor for Itamar Medical Ltd. He received an undergraduate degree from Bar-Ilan University.
Avraham Ben-Tzvi Presently, Avraham Ben-Tzvi is Secretary & Group Chief Legal Officer at Kitov Pharma Ltd. In the past he occupied the position of Secretary & General Counsel of Medigus Ltd. He received an undergraduate degree from Yeshiva University and a graduate degree from Shaarei Mishpat College.
Arye Weber Arye Weber occupies the position of Chairman of Scorpio Investments (A.W.) Ltd. He is also on the board of 6 other companies. In his past career Mr. Weber was Chairman of Inventec Investments Ltd., Chief Executive Officer of Alonei Meitar Ltd., Chairman for The Tel-Aviv Stock Exchange Clearing House Ltd. and Manager-Securities & Investments Sector at United Mizrahi Bank (Switzerland) Ltd. Arye Weber received an MBA from Kharkiv National University.
Ran Tzror Ran Tzror is on the board of Kitov Pharma Ltd. and Member of Israel Bar Association. In the past Mr. Tzror occupied the position of Senior Associate at Somekh Chaikin and President & Chief Executive Officer at Teva Pharmaceuticals Ltd. Mr. Tzror received a graduate degree and an MBA from Tel-Aviv University.
Revital Stern-Raff Revital Stern-Raff is on the board of Kitov Pharma Ltd.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐